Clinical Trials Directory

Trials / Completed

CompletedNCT01815996

Identify Clinical Conditions That Increase Circulating DNA Levels

Status
Completed
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The investigators are developing a test that is expected to measure the amount of radiation a patient has been exposed to after a nuclear bomb. The investigator will do this by measuring the DNA in the patients blood from cells killed by the radiation. Many diseases and medical conditions can put DNA in the blood. The investigator needs to know how much DNA in order to better interpret our radiation detection test. Therefore, the investigator is collecting blood from several patients with different diseases or medical conditions and also healthy volunteers to measure their DNA content. Patients that will be included in this study are pregnant women, patients who have suffered a pulmonary embolism within the past 48 hours, patients who have suffered from myocardial infarction in the past 48 hours, patients with autoimmune diseases and health patients.

Detailed description

The investigator will collect 8 mL (one and one half teaspoons) of blood one time only. The investigator may also collect the patient's past medical history, test results and disease treatment.

Conditions

Interventions

TypeNameDescription
OTHEROne time blood draw to look at patient's DNAOne time blood draw to look at patient's DNA

Timeline

Start date
2012-10-01
Primary completion
2016-07-28
Completion
2016-07-28
First posted
2013-03-21
Last updated
2018-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01815996. Inclusion in this directory is not an endorsement.